Targeted-release budesonide therapy for IgA nephropathy

Kenji Tsuda¹, Tetsuya Tanimoto², Jinichi Mori², Kazuhiro Kosugi³, Tsunehiko Komatsu⁴

Affiliations

¹ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan. Electronic address: thedod3@hotmail.com.
² Jyoban Hospital, Tokiwa Foundation, Fukushima, Japan.
³ Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
⁴ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan.

PMID: 29256403
DOI: 10.1016/S0140-6736(17)32145-1

Comment

Targeted-release budesonide therapy for IgA nephropathy

Kenji Tsuda et al. Lancet. 2017.

. 2017 Dec 16;390(10113):2625.

doi: 10.1016/S0140-6736(17)32145-1.

Authors

Kenji Tsuda¹, Tetsuya Tanimoto², Jinichi Mori², Kazuhiro Kosugi³, Tsunehiko Komatsu⁴

Affiliations

¹ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan. Electronic address: thedod3@hotmail.com.
² Jyoban Hospital, Tokiwa Foundation, Fukushima, Japan.
³ Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
⁴ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan.

PMID: 29256403
DOI: 10.1016/S0140-6736(17)32145-1

No abstract available

PubMed Disclaimer

Comment in

Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.
Fellström B, Barratt J, Flöge J, Jardine A. Fellström B, et al. Lancet. 2017 Dec 16;390(10113):2625-2626. doi: 10.1016/S0140-6736(17)32138-4. Lancet. 2017. PMID: 29256402 No abstract available.

Comment on

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators. Fellström BC, et al. Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28. Lancet. 2017. PMID: 28363480 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Targeted-release budesonide therapy for IgA nephropathy

Affiliations

Targeted-release budesonide therapy for IgA nephropathy

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous